AVP and ductal breast carcinoma in situ: The rate of patients with BC and/or DCIS significantly differed between the patient groups (p < 0.01, Fisher’s exact test): The highest rate was 17.5% (95% confidence interval (CI), 10.7–26.2) in patients within the group of ADH, FEA, and LN1-2.